YMAB icon

Y-mAbs Therapeutics
YMAB

Overview Fund Activity

59 hedge funds and large institutions have $251M invested in Y-mAbs Therapeutics in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+14
Holders Change %
+31.11%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
20
Increased
25
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BlackRock
BlackRock
New York
$26.4M
2
AG
Artal Group
Luxembourg
$9.15M
3
CAM
Cormorant Asset Management
Massachusetts
$22.9M
4
State Street
State Street
Massachusetts
$7.37M
5
Vanguard Group
Vanguard Group
Pennsylvania
$11.2M

Top Sellers

1
SCM
Scopia Capital Management
New York
$0
2
VIA
Vident Investment Advisory
Georgia
$1.52M
3
TAM
Tiverton Asset Management
Delaware
$113K
4
Barclays
Barclays
United Kingdom
$300K
5
FCM
Flinton Capital Management
Pennsylvania
$57K
Name Holding Trade Value Shares
Change 		Shares
Change %
MLICM
51
Metropolitan Life Insurance Company (MetLife)
New York
$36.3K +$36.3K +1,589 New
Canada Life
52
Canada Life
Manitoba, Canada
$32K +$32K +1,383 New
MCIM
53
Meadow Creek Investment Management
Georgia
$27K -$18.5K -800 -41%
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$19.6K -$13.5K -592 -41%
TRCT
55
Tower Research Capital (TRC)
New York
$17K +$12.1K +525 +244%
CSS
56
Cubist Systematic Strategies
Connecticut
$12K +$12K +520 New
PCM
57
Prelude Capital Management
New York
$10K +$10K +458 New
Morgan Stanley
58
Morgan Stanley
New York
$6K -$23.8K -1,104 -80%
Rockefeller Capital Management
59
Rockefeller Capital Management
New York
$3K – – –
SCM
60
Scopia Capital Management
New York
– -$24.1M -920,282 Closed
MWNA
61
Marshall Wace North America
New York
– -$19K -735 Closed
CCA
62
Catalyst Capital Advisors
New York
– -$10K -400 Closed
1 2
3